Award

Delivery Order #SPE2DR26F8AFJ

Pharmaceutical Delivery Order for Novolin N Vials by AmerisourceBergen

Buyer

Defense Logistics Agency

Award Amount

$724.12

Ceiling

$724.12

Awarded

March 06, 2026

Period of Performance

Mar 06, 2026 – Mar 09, 2026

Identifier

SPE2DR26F8AFJ

NAICS

325411

This delivery order contract represents a specific procurement action under a longstanding indefinite delivery vehicle (IDV) awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company specializing in drug supply and related services. The contract focuses on the acquisition of Novolin N insulin vials, a critical pharmaceutical product used in diabetes management, ensuring the availability of essential medication. This delivery order supports the broader scope of the parent IDV, which is aimed at sustaining long-term pharmaceutical supplies for health agencies, thereby bolstering public health initiatives. The work involves timely delivery of the specified medical product to fulfill agency needs. The contract was issued under the existing IDV arrangement, leveraging AmerisourceBergen's established role, and was awarded based on this procurement vehicle. The operation is scheduled for a short, definitive performance period, highlighting its role as a targeted supply action within a larger ongoing pharmaceutical support program.

Description

4571051303!NOVOLIN N 100 UNIT/ML VIAL 10ML

View original record